Results for 'OS'
Find oncology podcasts about OS — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.
Dr. Rebecca Previs
Advancing Endometrial Cancer Care with Molecular Profiling
endometrial cancer care, prognosis, precision treatment
How molecular profiling of GOG258 is changing advanced endometrial cancer care—insights on POL-E, prognosis, and precision treatment.
May 14th • 32 mins listen
The Pulse of the Oncologist: Listening to What Matters Most
diagnostic, digital, molecular residual disease, MRD
Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.
Apr 14th • 22 mins listen
Monty Pal
How Engineered Antibodies and Next Generation Imaging Tools are Reshaping Cancer Care with Anna Wu, Ph.D.
City of Hope, Academic Research, engineered antibodies, PET, imaging, radioisotope, CEA directed agent, PSCA targeted radiopharmaceutical, pancreatic cancer, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Anna Wu, Ph.D., Chair of the Department of Immunology and Theranostics at City of Hope, joins host Monty Pal, M.D., for an engaging discussion on how innovations in antibody engineering and imaging are improving clinicians’…
Mar 9th • 42 mins listen
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest, Diagnostics, MRD, minimal residual testing, precision, biomarker
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Monty Pal
Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery
City of Hope, Academic Research, ASCO, precision, AI, dose strategy
Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.
Jun 23rd • 43 mins listen
Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer
diagnostic, genetic counselor, genetic testing, prostate cancer, urologic oncology, digital
Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.
May 18th • 19 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
diagnostic, biomarker, lung cancer, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
diagnostic, ovarian cancer, biomarker, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
ctDNA Breakthroughs in Mesothelioma Care
diagnostic, immunotherapy, imaging
Exploring immunotherapy and ctDNA innovation in mesothelioma, where molecular monitoring may redefine early cancer detection and treatment.
Nov 3rd • 15 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
Rebecca Previs
Navigating the Future of CDXs in Oncology
precision oncology, companion diagnostics, CDx, biomarker, precision medicine
CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.
Feb 18th • 26 mins listen
Monty Pal
Translating Discovery: Shaping Tomorrow’s Prostate Cancer Therapies
City of Hope, Academic Research, immunotherapy, prostate cancer
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal welcomes Dr. Tanya Dorff, professor in the Department of Medical Oncology & Therapeutics Research and section chief of the Genitourinary Disease Program at City of Hope. Together they dive into Dorff’s pionee…
Nov 25th • 31 mins listen
Monty Pal
What it Takes to Close the Gap in Pediatric Cancer Care with Leo Wang, M.D., Ph.D.
City of Hope, Academic Clinical Research, CAR T‑cell therapy gene therapy
In this episode, Leo Wang, M.D., Ph.D., pediatric oncologist, Clinical Director of the Gene Therapy Program and Director of the City of Hope Alpha Clinic, discusses the realities of caring for children with cancers that still have few effective treatments. He reflects on what it takes to begin chang…
Apr 21st • 46 mins listen
Monty Pal
At the Crossroads of Cancer and Metabolism
City of Hope, Academic Research, metabolic dysfunction, GLP-1
Dr. Charles Brenner explores the metabolic links between cancer, diabetes, NAD, and the future of liver-focused therapies.
Jul 7th • 37 mins listen
Monty Pal
Asking the Impossible: How Bold Questions are Unlocking Diabetes Biggest Breakthroughs
City of Hope, Academic Research, diabetes, microbiome
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal sits down with Dr. Alberto Pugliese, Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and director of The Wanek Family Project for Type 1 Diabetes. Tune in to disc…
Nov 10th • 51 mins listen
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
Kirk Shepard
Recruiting for Impact: Inside the Oncology Talent Market
recruiting, oncology recruiting
Get the real story on oncology recruiting: Michael Pietrack explains the hiring disconnects and strategies behind top-performing executive teams.
May 12th • 20 mins listen